As the functional enrichment analyses suggest that TRIM58 is correlated with the genes involved in the AKT pathway in CRC (Fig. 1G), the AKT inhibitor LY294002 was used to rescue the function of TRIM58. This evidence concerns the gene AKT1 and colorectal carcinoma.